— Know what they know.
Not Investment Advice

ALKS NASDAQ

Alkermes plc
1W: -3.7% 1M: +9.5% 3M: +15.8% YTD: +30.8% 1Y: +16.7% 3Y: +19.1% 5Y: +66.0%
$36.80
-0.15 (-0.41%)
 
Weekly Expected Move ±6.0%
$33 $35 $37 $40 $42
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 66 · $6.1B mcap · 163M float · 1.48% daily turnover · Short 54% of daily vol

📊 Key Metrics

TTM
$2B
Revenue
+3.2% YoY
$153M
Net Income
-56.7% YoY
$222M
Free Cash Flow
-53.9% YoY
84.3%
Gross Margin
-12.3%
Op. Margin
-16.9%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE9.3%
ROA6.7%
ROIC25.2%

Valuation

P/E40.0
P/B3.5
EV/EBITDA16.7

Leverage

Debt/Equity0.04
Current Ratio3.55
Interest Cov.7.2x

Quality Scores

Piotroski F7/9
Altman Z6.14
Beneish M-2.80

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms